The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Oral mucositis
Abstract
Mucositis and xerostomia are the most common oral complications of the non‐surgical therapy of cancer. Mucositis, a common sequel of radio‐ (DXR), chemo‐(CXR) and radiochemo‐therapy in patients with cancer, or patients requiring haemopoietic stem cell transplants (HSCT), has a direct and significant impact on the quality of life and cost of care, and also affects survival – because of the risk of infection. Apart from dose reduction, preventive and treatment options for mucositis are scarce, although multiple agents have been tested. Evidence suggests that cryotherapy, topical benzydamine and amifostine might provide some benefit in specific situations. The recombinant human keratinocyte growth factor Palifermin (Kepivance®) was recently approved as a mucositis intervention in patients receiving conditioning regimens before HSCT for the treatment of haematological malignancies. A number of mechanistically based interventions are in various stages of development. Unfortunately, many other approaches have not been rigorously tested. This paper reviews the clinical features, prevalence, diagnosis, complications, pathogenesis, prophylaxis and management of mucositis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., et al. (2004) · Cancer · doi:10.1002/cncr.20162 · Cited by 1,417
Self-citationSonis, S. T. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1318 · Cited by 1,361
Self-citationTrotti, A., Bellm, L. A., Epstein, J. B., Frame, D., Fuchs, H. J., Gwede, C. K., Komaroff, E., Nalysnyk, L., & Zilberberg, M. D. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00404-8 · Cited by 1,211
Gabrilove, J. L., Jakubowski, A., Scher, H., Sternberg, C., Wong, G., Grous, J., Yagoda, A., Fain, K., Moore, M. A. S., Clarkson, B., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806023182202 · Cited by 938
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040125 · Cited by 893
O ral S equelae of H ead and N eck R adiotherapy
Vissink, A., Jansma, J., Spijkervet, F. K. L., Burlage, F. R., & Coppes, R. P. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400305 · Cited by 829
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3339 · Cited by 828
Rubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L. S., Fox, P. C., Cooksley, C., Sonis, S. T., et al. (2004) · Cancer · doi:10.1002/cncr.20163 · Cited by 820
Self-citationSonis, S. T. (1998) · Oral Oncology · doi:10.1016/s1368-8375(97)00053-5 · Cited by 565
Self-citation
Cited by
Yang, L., & Pan, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153800 · Cited by 12
Ecdysterone Attenuates the Development of Radiation-Induced Oral Mucositis in Rats at Early Stage
Yang, L., Friedemann, T., & Pan, J. (2021) · Radiation Research · doi:10.1667/rade-21-00042.1 · Cited by 5
Li, Y., Ailing, H., & Jian, P. (2019) · Radiation Research · doi:10.1667/rr15171.1 · Cited by 5
Metadata
- Authors
- Scully, C., Sonis, S., & Diz, P.
- Venue
- Oral Diseases
- Publisher
- Wiley
- Published
- 2006-05
- Volume
- 12
- Issue
- 3
- Pages
- 229-241
- ISSN
- 1354-523X (ISSN-L)
- 1601-0825
- OpenAlex
- W4211097868
- Cited by
- 253
- References
- 74
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral mucositis. https://app.cochat.ai/papers/10.1111/j.1601-0825.2006.01258.x
- The paper
- Scully, C., Sonis, S., & Diz, P. (2006). Oral mucositis. Oral Diseases. https://doi.org/10.1111/j.1601-0825.2006.01258.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.